United States Computational Biology Market Trends & Industry Analysis | Major Players 2025 - Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd

"Computational Biology Market is anticipated to grow at high CAGR during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/computational-biology-market?sp

United States: Recent Computational Biology Developments

✅ In September 2025, Regeneron Pharmaceuticals launched a new AI-driven computational biology platform in New York.The system integrates genomics, proteomics, and phenotypic data to accelerate target discovery for drug development.It enhances precision medicine and reduces R&D timelines.

✅ In August 2025, Insitro invested $40 million to expand its computational biology research and AI infrastructure in California.The expansion focuses on integrating machine learning with high-throughput biological data.Commercial applications are expected by Q1 2026.

✅ In July 2025, Recursion Pharmaceuticals introduced a cloud-based computational biology platform in Utah.The system leverages automated high-content imaging and AI analytics to identify therapeutic candidates.It supports rapid drug repurposing and novel discovery.

✅ In June 2025, Tempus completed the rollout of an advanced computational biology platform in Illinois.The platform integrates multi-omics data with clinical insights to guide personalized treatment strategies.It strengthens oncology and rare disease research pipelines.

Japan: Recent Computational Biology Developments

✅ In September 2025, Riken Center for Integrative Medical Sciences launched an AI-enabled computational biology platform in Tokyo.The platform supports integrative analysis of genomic and clinical data for translational research.It advances precision medicine initiatives nationwide.

✅ In August 2025, Fujitsu invested in high-performance computing infrastructure for computational biology in Osaka.The initiative focuses on drug discovery and biomarker identification using AI and large-scale data analytics.Pilot projects are ongoing in collaboration with pharmaceutical companies.

✅ In July 2025, Kyoto University introduced a cloud-based computational biology system for genomics research in Kyoto.The platform enables large-scale data analysis, predictive modeling, and simulation of biological processes.It supports academic and translational research initiatives.

✅ In June 2025, Takeda Pharmaceuticals completed testing of a next-gen computational biology platform in Fukuoka.The system integrates multi-omics data, clinical trials, and AI analytics to accelerate drug discovery.It will be deployed across R&D sites nationwide.

Computational Biology Market: Drivers

The computational biology market is experiencing rapid growth as researchers, pharmaceutical companies, and academic institutions increasingly leverage computational tools to understand complex biological systems and accelerate drug discovery. Rising adoption is driven by the need to analyze large-scale genomic, proteomic, and metabolomic data, enabling insights into disease mechanisms, biomarker identification, and personalized medicine. Additionally, the growing demand for in silico modeling, simulation, and predictive analytics in drug development and systems biology is fueling market expansion. Increasing investments in biotechnology, precision medicine, and advanced research infrastructure further support growth. The rising integration of artificial intelligence and machine learning is also enhancing capabilities across computational biology applications.

Technological advancements are significantly enhancing computational biology. Innovations in high-performance computing, cloud platforms, and big data analytics allow efficient processing and interpretation of massive biological datasets. AI and machine learning algorithms enable predictive modeling, drug target identification, and personalized therapeutic solutions. Development of bioinformatics tools, simulation software, and systems biology platforms improves accuracy, reproducibility, and speed of research. Advances in visualization technologies, network analysis, and multi-omics integration provide deeper insights into cellular pathways and disease progression. With ongoing innovation and increasing adoption in research and healthcare, the computational biology market is poised for substantial growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/computational-biology-market?sp

Computational Biology Market: Major Players

Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd., Certara., Nimbus Therapeutics., Athos Therapeutics, Thermo Fisher Scientific Inc., Schrödinger, Inc., Fios Genomics, Illumina, Inc. among others.

Segment Covered in the Computational Biology Market:

➥ By Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software

➥ By Tool: Databases, Infrastructure, Analysis Software and Services

➥ By Service: In-House, Contract

➥ By End User: Academic & Research, Industrial, Commercial, Others

Research Process:

Both primary and secondary data sources have been used in the Computational Biology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Computational Biology Market Research Industry:

➠ Who leads the Computational Biology industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Computational Biology market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Computational Biology market growth?
➠ What are the dominant sales and distribution strategies in the Computational Biology industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=computational-biology-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.